Pablo Mandó

Peripheral changes in immune cell populations and soluble mediators after anti-PD-1 therapy in non-small cell lung cancer and renal cell carcinoma patients

Estefanía P. Juliá, Pablo Mandó, Manglio Rizzo et al. · Cancer Immunology Immunotherapy · 2019 · 51 citations · Full text

Cancer Immunosurveillance, Medicine, Immunology +10

Breast Cancer in Young Women Presents With More Aggressive Pathologic Characteristics: Retrospective Analysis From an Argentine National Database

Verónica Fabiano, Pablo Mandó, Manglio Rizzo et al. · JCO Global Oncology · 2020 · 51 citations · Full text

Association between risk-reducing surgeries and survival in young BRCA carriers with breast cancer: an international cohort study

Eva Blondeaux, Amir Sonnenblick, Elisa Agostinetto et al. · The Lancet Oncology · 2025 · 31 citations

Young Brca Carriers, Surgical Oncology, Breast Oncology +11

Efficacy and Safety of Nivolumab in Previously Treated Patients With Non–Small-cell Lung Cancer: Real World Experience in Argentina

Claudio Martín, Lorena Lupinacci, Florencia Perazzo et al. · Clinical Lung Cancer · 2020 · 23 citations

Non–small-cell Lung Cancer, Oncology, Cancer Management +6

High neutrophil to lymphocyte ratio and decreased CD69<sup>+</sup>NK cells represent a phenotype of high risk in early-stage breast cancer patients

Pablo Mandó, Manglio Rizzo, María Paula Roberti et al. · OncoTargets and Therapy · 2018 · 14 citations · Full text